Drug Report History

Return to report

Below you will find the report version history. When a report is updated, a new version of the report is created. The report history allows you to see the changes between versions. You can select two versions of the report to compare. The fields that were changed between versions will be highlighted in yellow.

The translation of reports creates two separate versions which is why some reports may not seem to have any differences. In this case, only the language field below will be highlighted in yellow.

Version v7-FR Version v1-EN
Language French English
Date Updated 2020-11-05 2020-09-09
Drug Identification Number 02106280 02106280
Brand name TRANDATE TRANDATE
Common or Proper name Trandate Trandate
Company Name PALADIN LABS INC. PALADIN LABS INC.
Ingredients LABETALOL HYDROCHLORIDE LABETALOL HYDROCHLORIDE
Strength(s) 200MG 200MG
Dosage form(s) TABLET TABLET
Route of administration ORAL ORAL ORAL ORAL
Packaging size 100 tabs 100 tabs
ATC code C07AG C07AG
ATC description BETA BLOCKING AGENTS BETA BLOCKING AGENTS
Reason for shortage Other (Please describe in comments) Other (Please describe in comments)
Anticipated start date 2020-09-14 2020-09-14
Actual start date 2020-09-11
Estimated end date 2020-11-30 2020-11-30
Actual end date 2020-10-07
Shortage status Resolved Anticipated shortage
Tier 3 Status No No
Company comments Product on allocation - Orders may not be shipped entirely Product on allocation - Orders may not be shipped entirely
Health Canada comments